Studies in Pharmaceutical Economics

Első borító
CRC Press, 1996. okt. 11. - 586 oldal
Readers of Studies in Pharmaceutical Economics learn the value of economic research in forming health policy while they develop an understanding of the various factors that influence the cost of pharmaceutical care for patients, pharmacists, physicians, and manufacturers. Pharmaceutical economists, product managers, and policymakers learn different methods for controlling costs, patient compliance, therapeutic outcomes, and the effects of restrictions on prescription drugs on the use and cost of other health care services. Above all, readers will find this book provides them with the necessary `know-how’for survival in the dynamic and competitive health care marketplace.

The chapters of Studies in Pharmaceutical Economics range in scope from editorials to technical papers on new research methods. Readers will find the following key topics covered:
  • pricing strategies
  • marketing implications
  • policy issues
  • methods for controlling utilization and cost
  • multi-tier pricing and its effects on pharmacists and consumers
  • analytical approaches to research

    This valuable guidebook to the conditions characterizing the growing field of pharmacoeconomics maps the effects of clinical pharmacy services on the lengths of hospital stays, on hospital admissions, on adverse reactions, and on physician’s methods and habits of prescription. It also provides readers with practical policy applications and means for assessing trends in the market. These include the effects of extending Medicare coverage to outpatient prescription drugs and a technique for incorporating severity-of-illness measures into analysis of the cost-effectiveness of treatment.

    Professors of pharmacy administration and their students, product managers and pharmaceutical economists in the drug industry, and drug program administrators can use Studies in Pharmaceutical Economics as an introduction to the ways in which pharmaceutical economic research can bring efficiency and cost-effectiveness into their programs.

    Professors of pharmacy administration and their students, product managers and pharmaceutical economists in the drug industry, and drug program administrators (medical, HMOs, in service companies) can use Studies in Pharmaceutical Economics as an introduction to the ways in which pharmaceutical economic research can bring efficiency and cost-effectiveness into their programs.

Részletek a könyvből

Mit mondanak mások - Írjon ismertetőt

Nem találtunk ismertetőket a szokott helyeken.

Tartalomjegyzék

PUBLIC POLICY ISSUES
1
An Independent Assessment
10
Health Policy Initiatives and the Utility
25
Specific Policies and Concerns About Methodologies
31
Paying
39
Conclusion
66
Nonoptions
74
INTERVENTIONS AND CONTROLS
83
Issues in the Measurement of QALY
264
PRICES AND PRICING
273
The German Prescription Drug System
281
Conclusion
288
Physicians Perceptions of Prescription Drug
305
Beliefs and Opinions
314
Methods
322
Discussion
328

Data
93
Concluding Comments
101
Incorporating SeverityofIllness Measures
103
Initial Impact of a Medicaid Prior
113
Conclusion and Discussion
124
Data and Methods
130
Conclusion
137
Impact of an Open Formulary System
143
Results
149
Discussion
159
Limitations
165
A Research Framework for Economic
171
Summary
179
Fundamental Concepts of Economic Analysis
186
Assessment of a Contingent Valuation
193
Results
201
Discussion
207
Using Repeated Measures Designs
215
Dependent Measures
222
Magnitude of Effects
228
Methods
234
Measurement of QALY
257
An Exploratory Study of Physician Perceptions
335
Limitations
343
Toward an Understanding of Pharmaceutical
345
Conclusion
356
ECONOMICS AND MARKETING
389
Results
395
Discussion and Conclusions
401
DirecttoConsumer Advertising
407
The Role of Health Economics in Marketing
415
Entry Prices
433
ECONOMICS OF NONCOMPLIANCE
441
Noncompliance with Medication Regimens
467
EFFECTS ON PHARMACY
481
The Tools of Managed Care
494
Provider Reimbursement in Public Programs
500
Effects of Managed Care of Pharmacy Services
506
Analysis of the Impact of ThirdParty
517
Chapter32 ThirdParty Associated CostShift Pricing
530
Pharmacy Participation in ThirdParty
545
Strategic Implications
554
Copyright

Más kiadások - Összes megtekintése

Gyakori szavak és kifejezések

Bibliográfiai információk